Inhibition of chicken myeloblastosis RNA polymerase II activity by adriamycin.
In vitro RNA synthesis by isolated RNA polymerase II of chicken myeloblastosis cells was shown to be highly sensitive to adriamycin inhibition. The template activity of the single-stranded DNA, purified by chromatography of denatured calf thymus DNA through hydroxylapatite columns, was found to be equally as sensitive to the inhibition as denatured calf thymus DNA. However, contrary to denatured DNA, the single-stranded DNA thus purified showed no significant binding to adriamycin as analyzed by cosedimentation of the drug and DNA through a sucrose gradient. This indicated that inhibition of RNA synthesis on a single-stranded DNA template might involve a mechanism other than DNA intercalation. Kinetic studies of the inhibition showed that the inhibition of RNA synthesis by adriamycin could not be reversed by increasing the concentrations of RNA polymerase and four nucleoside triphosphates, but it could be reversed by increasing DNA concentrations. Analysis of the size of RNA synthesized indicated that the ultimate size of the product RNA was not altered by adriamycin, suggesting that the drug may inhibit RNA synthesis by reducing RNA chain initiation.
D000818:Animals; D002645:Chickens; D004247:DNA; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors*; D004317:Doxorubicin / Q000494:pharmacology*; D007700:Kinetics; D007942:Leukemia, Experimental / Q000201:enzymology*; D008970:Molecular Weight; D011485:Protein Binding; D012319:RNA Polymerase II / Q000037:antagonists & inhibitors*; D013698:Templates, Genetic; D014158:Transcription, Genetic
D004317:Doxorubicin; D004247:DNA; D012319:RNA Polymerase II; D012321:DNA-Directed RNA Polymerases